Exenatide
Exenatide Once Weekly for Smoking Cessation
AstraZeneca · Phase 1/2 · Completed · Enrollment 84
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Exenatide plus NRT plus counseling | n/r | n/r | n/r | n/r |
| Placebo plus NRT plus counseling | n/r | n/r | n/r | n/r |
Not shown
- Exenatide plus NRT plus counseling: endpoint not reported
- Placebo plus NRT plus counseling: endpoint not reported